0001399529-20-000066.txt : 20200916 0001399529-20-000066.hdr.sgml : 20200916 20200916073929 ACCESSION NUMBER: 0001399529-20-000066 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20200916 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200916 DATE AS OF CHANGE: 20200916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205993609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 201177415 BUSINESS ADDRESS: STREET 1: 33 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 33 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 8-K 1 drna-20200916.htm 8-K drna-20200916
FALSE000139952900013995292020-09-162020-09-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________________________________
FORM 8-K
__________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 16, 2020
__________________________________________________
DICERNA PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
__________________________________________________
Delaware001-3628120-5993609
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification Number)
33 Hayden Avenue
Lexington, Massachusetts
 
 02421
(Address of registrant’s principal executive office)
 (Zip code)
(617) 621-8097
(Registrant’s telephone number, including area code)


(Former name or former address, if changed since last report)
__________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareDRNAThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company  



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 8.01 Other Events.
On September 16, 2020, the Company announced that Ling Zeng was appointed to serve as the Company’s Chief Legal Officer and Secretary, effective as of September 16, 2020. In connection with such appointment, the Company issued a press release on September 16, 2020, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No.
Description
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document).




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 16, 2020DICERNA PHARMACEUTICALS, INC.
By:
/s/ Douglas M. Fambrough, III
Douglas M. Fambrough, III, Ph.D.
Chief Executive Officer

EX-99.1 2 drna20200916ex991.htm EX-99.1 Document
Exhibit 99.1
image011.jpg
Dicerna Appoints Ling Zeng as Chief Legal Officer and Secretary
– Biopharmaceutical Industry Veteran Brings Expertise in Global Drug Development and Corporate Governance –
LEXINGTON, Mass., Sept. 16, 2020 -- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the appointment of Ling Zeng as chief legal officer and secretary and a member of the Company’s executive leadership team, effective immediately.

“Ling is a proven legal expert with deep and diverse biopharma experience, from research through global commercialization, and we welcome her to our management team,” said Douglas Fambrough, Ph.D., president and chief executive officer of Dicerna. “Ling’s significant knowledge of global drug development, combined with her extensive strategic alliance and corporate governance experience, will be especially valuable as we continue to advance core and collaborative discovery and development programs and evolve as a company into a fully integrated commercial-stage organization.

“I would also like to thank Bruce Leicher, who has served as our acting general counsel and chief compliance officer since early 2019,” Dr. Fambrough continued. “Dicerna has benefitted significantly from Bruce’s counsel and experience as a longtime strategic legal advisor in the biopharmaceutical industry, and we appreciate his contributions to Dicerna’s growth and successes over the past two years.”

“Dicerna has brought together a highly motivated, talented team of patient-focused leaders who are driven to bring forward new RNAi therapies to benefit human health,” said Ms. Zeng. “Built upon an entrepreneurial culture in an area that is increasingly recognized as one of the most promising fields of drug development, I am energized and excited to be joining Dicerna at such an important time in its growth trajectory, and I look forward to contributing to Dicerna's continued success.”

Over a career spanning more than two decades in the life sciences industry, Ms. Zeng has gained broad and deep experience in biopharmaceutical law and global drug development, and has held multiple leadership positions in North America, Europe and the Asia-Pacific region. Ms. Zeng joins Dicerna from Novartis AG where she served as deputy head of the legal M&A group responsible for mergers and acquisitions (M&A). In her role, Ms. Zeng was responsible for M&A across all business units and regions. Prior to Novartis, Ms. Zeng held several senior-level positions at Bausch Health Companies, Inc., most recently as vice president and general counsel for Europe, the Middle East and Africa (EMEA), where she was responsible for EMEA legal matters in over 30 countries, and provided counsel on business development efforts, commercial operations, compliance, regulatory and IP strategies, and M&A transactions and integrations. Earlier in her career, Ms. Zeng was an associate at Cleary, Gottlieb, Steen & Hamilton in New York. Ms. Zeng was a research scientist prior to beginning her legal career.

Ms. Zeng earned her Juris Doctor degree from Georgetown University where she graduated cum laude. Ms. Zeng holds a Master of Science in biophysics from Brandeis University and a Bachelor of Science in physics from Peking University.

About Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) is a biopharmaceutical company focused on discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference


Exhibit 99.1
(RNAi) to selectively silence genes that cause or contribute to disease. Using our proprietary RNAi technology platform called GalXC™, Dicerna is committed to developing RNAi-based therapies with the potential to treat both rare and more prevalent diseases. By silencing disease-causing genes, Dicerna’s GalXC platform has the potential to address conditions that are difficult to treat with other modalities. Initially focused on hepatocytes, Dicerna has continued to innovate and is exploring new applications of its RNAi technology beyond the liver, targeting additional tissues and enabling new therapeutic applications. In addition to our own pipeline of core discovery and clinical candidates, Dicerna has established collaborative relationships with some of the world’s leading pharmaceutical companies, including Novo Nordisk A/S, Roche, Eli Lilly and Company, Alexion Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH and Alnylam Pharmaceuticals, Inc. Between Dicerna and our collaborative partners, we currently have more than 20 active discovery, preclinical or clinical programs focused on rare, cardiometabolic, viral, chronic liver and complement-mediated diseases, as well as neurodegeneration and pain. At Dicerna, our mission is to interfere – to silence genes, to fight disease, to restore heath. For more information, please visit www.dicerna.com.

Cautionary Note on Forward-Looking Statements
This press release includes forward-looking statements relating to our business and operations, including the development of our product candidates and technology platform, as well as the therapeutic potential thereof. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Applicable risks and uncertainties include those relating to our preclinical research and clinical programs and other risks identified under the heading "Risk Factors" included in our most recent Form 10-K filing, our subsequent filings on Form 10-Q and in other future filings with the Securities and Exchange Commission. The forward-looking statements contained in this press release reflect Dicerna's current views with respect to future events, and Dicerna does not undertake and specifically disclaims any obligation to update any forward-looking statements.

GalXC™ is a trademark of Dicerna Pharmaceuticals, Inc.

###

Contacts
Media:
Amy Trevvett
+1 617-612-6253
atrevvett@dicerna.com

Investors:
Lauren Stival
+1 617-514-0461
lstival@dicerna.com

EX-101.SCH 3 drna-20200916.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 drna-20200916_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 drna-20200916_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 drna-20200916_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 drna-20200916_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 image011.jpg begin 644 image011.jpg MB5!.1PT*&@H -24A$4@ X4 # " 8 "SK<;B "7!(67, $SE M !,Y0%USO"5 !W3$E$051XG.R]!WA65?:W_7_?[_V^=T! 12QCP3[6L8Y= M1\<^%GKOO?B] ((6$E@(A$ A)@!12"*1 ")"0WD@ ?]]>.XD: M125XSO,\)\^ZKVM=.@-"3MMGWV>OO=;_W#'0#$K%[0-,T7/ 1G3K_X,($_RM M'\5&CC^)'N*\W?Z+\WC78 O'N> EV=[X*,5 1AK$8%EGK&P"3N"X/U9B#M1B!-G+N)<>0W*:QI1W]2" MYJO7I2+?U:) MAZFVL5F>EZ;FJZH\6 S#, S#,$S7([?D,OSV9PAIBL4 TZUX9;'';^+%A6YX M?KXKGI[C@L=F.*+O- <\)?[]I47N-_S][4'BMS^S"&FG+R#QY%FX[CF&3]<% MH?<8:\SWV(N4_/,X7U$KYKI7%3L>\@/R!)HKAQP\B6DN.S'5.1JSA?3.\]@C M?\__]) BITSC6)H8_GTLSW#'8 G<-L\*#8^SPY"0GO#3; M'>\M\<47JX,Q](=03+&)PBJ??;"/.(JHY%,X65R&BU7U4H"Z,B2#)(*E%?7( M*ZE RJE2[,\HQHXCIQ":F(/ ?5GRWP^>/">E.>?L911=K);B2+[\8Q>79H9A M&(9A&.:O4516C:C44[#9D8Q%WC$891/VFQADMA6?K O$Z\N\\*B0PCO'6N&5 M)1X88A%ZP]_?'@[11Y&:7XHC>278>B@'JX,2\-8*'_0<98$AYJ%PVYN&P^+7 MJL5\5RE(,$D(3Q1>Q/HMB7A-_,SO?^LOCB$4(ZW#Y._Y'WT+$4902(CH.^<-!J7U7]%127 MU>#XZ8O8DWH&_G&9L-F>C&]]]V.A:PRFVD9CE?AWUYW'L%5(XLZCIZ4@%ERH M0N.5J_+CA'#CO3L4/H8F_B65^L9A@'RG% MD*3P_QVZ$>^O]LF.6VTZYFG>AJDZQ^6I=4S/RSE=@Q]%3&&<7B;\--\.#4^WQSDI??/I=D/P] M+(4:C&[]*-U47,S1=GAN^B9\_FT0IME'87U@ MQW'\>>M#,X55(ATRM;KEY3 MY&;2!_0<7!,"U]A\54I=4O8YF3IKNN4@EGK$8*9#-,9:A&/0]UOQN9#C#Y?[ MXYU%/OA,G(_A&[=CDO4.3+??*61Q+S:$'(3KKF/8EUZ$\Y?K4"\>#DXI91B& M81B&87X-;4&BU<+THHLXE'L.L1F%OXG@Q"QLW'8($QUVX(6%[OB_PTWEJAN) MY(U^?WMD%E]"674]4O)+X;([[2+H#WO[&!R;BS\T^5RXS &DN_%>Y M4%F'2"&$WP;NQW_6!.#_&V;*4MA5@L2P!^WC'&2./L,L\??15GAAYB9\N298 M[CWQ,>'&LCCMD&]XZT MP3TCK,4YL,)=XCS<.<1"_OO=(ZS$KUGCOE$VZ#O.'O^0L[DHJ;_C[VZ.]UD76V7*X[3W^DQ3^K\$F4M:ZCS3'9*(T--3G?'9JD AAC'PCTN7 MJVN40TPK8Y12J@5(8LECZ4&@?8%A23E"YA(QQBP,;R[P%,)G*8YY VYVW^IM M TS11YR;A\;98= /6V$B_JR(P[G(/7=95G=28GZ7P?P9MP/\2\;\'FQV3;2'S\30#^,=E) MKOSU'&1VTT)(T:W_1O00_\WM@\WQZ 1[O#+'%;/$ QB>E(O""U5_Z6%C&(9A M&(9AC \UI/!_B_@_0@H_61L(J_ CV)=9A%(QA[]5VK/NCN:78IKS3MPUUAIW MC+9$K]'F>&*6$]Y;Y<=2V+6#A&D#[AYNCA$;0^&^^QCV913)*IPU#4 MQUU\J1H[CY[" M?=0N+<';KW-U7DW%#+E+<6>F*U;SRBDO-PIK12WX?, M, S#, S#: BEI?!_#S;!;2/,T6>L%=Y9X8.I3M%PVWL,.>7>.<;'UEPYI-U02R%QA;_6>:' M=?X'I!CFBQO$D!NZ'\DIP2J?>'RTPA^/37!0Y7QT$V)X6W\3O+W0$UY[CJ&V M\8K<6\ARR# ,PS ,P_P92DLA52]]40CA,(M0O+',"[>/L<1':P.Q[7 NZAJ; MT7P+!1(/YIS%(N^]>&^5+YZ;MPF/3'/ 6\M]Y)[%_ANWXO/UP2R%QA:T'^^S ME0%8[+97MG5(+[B(2]4W=]/JFKCCA9AD'8FGICC+RJ)JG ]:=>PN@O9>KO"* M1@[?Z&)V<@1-Z,A$GDD3Z:\4LN-[HJDC/Y^/#S.'H.^WP*3 MS8ERWZ6A[[=D&(9A&(9A](_24MA[G!56^,>AX&(E;"*.X/FYF_#J(@\L]8Y! MV)%=C]+*6GC%'L='J_WQQE)/ M#+?8AO6;#^!@SKF;_MDN5M4CO>@2K(1YX:X4/''>FR!5 *HYX_7?FZS2/IU_;=>PT%GCNE=+WPD)W MN7&R\ RR$(-JX-3L";0@B?FK,)*_SC9371PDO5:+E!!P$20MH.UG+U&KSC3N"CM0%X M?9F7E#X2Q)@3!:BH:T20D,/Q=KQ2R-$6MPTPQ9U#+?#P!'M9>.9HWGDIAOK< M4[ZH,\P2]VAGB@?'""GA"?GH:ZI^3=_'JT>EE;6(:/HDJQBVG>: MO>Q/:!E^&$FYYV3J*$LAQ^\&K1A2&NG7ZT)@&YXL&]OK:U\A26%_\7/H6@HI M: \C2R'#, S#, QS,Z@IA5=:KLHM72GYI5CA%X\/5P?@O96^^(_X>UQVI\DT MT%]/UVF5,*NX##M2\C#-.0KW3;+&5QN"$7DT3PKFE99K+(4PM/G:_ ]L.Y M&&4=AKO&66& Z1981QY!O)!%^KNHVBBUJ:"]A N]]N+.,19XYQL?3'..AE?L M"2F/[5O#6 HY_C1("E^8Z8K1%N%PB$Q!1N$EU1ZBWR-!R.CZP$0,^&X+'IW@ MH)/COGVP.1X<8XLW%WC")2J5I9!A&(9A&(;Y4W0AA21\5%0F[70I%@GA>VRZ M(S[XUD^FA7K$'I<52FDO(67Y)6058XKC#OQMF E&6&['9B%_F4(4:3]A.RR% M'#<5?GX6YSKN%H+K)5;QN*A_S7<,L M\<(L5PSZ?@L"XC-N6.*781B&81B&87Z)+J2PG>*R:EA'',%_A!#^>Y4OWOG& M&VN"]R.]\*)L*7XL\:)$2OV["-F..V&R<*+DH);/E%G1"60HZ;BKN' M6^$?DQPQWB(F.$H*XSNSRI" MZNE269%TJE.T3!OM/=82RWSCD%]:*>>UUW]1IM0@I%#VQ6LK:'(S085&[AEA MA7M'6&LJ[A%!N_]CAAM05>U+/8-B&;;*A/)TSM>Y'6HE\>JHSIMI%P28IZYHC.27XUF<_ M/EX1@"+T"0<.WU!/#QU';ZF, S#, S#,,R-T*44 M-HGY.*60)N6885W%_M@O%7D3<4JGWA9^,-[[PG-A/NN8W"(/ K3+8>PQ#U&'$?$ M3\N+%&:YX;(*C7&'L-=A4>7(Z05Y)!?SC,N7>PM?G>XCSL4'Q\T&KN4]-<<9(T^V(/-*V M*LI"R# ,PS ,P]P$NI1"FJ*V7+TN%VS,PPX+ 73!P],<\/P\5SPUVQF]QUK@ MWHG6F.RT ]N/Y,A*I# =,L=T!W]CTFXH=R:=P,.LLDG-+-!.' MLTMP(+,8,<<*L/U0+OSB,GYQ3!DR/'8?AT-$"BQ"#V/CYD/8$)2(U;[[L=0C M5IZ?K]>%X TA0H^,MT./ ::RN;RNI?"%66Y8[ADG>Q:>$H*F:RY5U>-H7JD4 M[X88X''9CA@94"\+#Y# M_0U;KEW_S=]I$%+XW/1-L-IV6%;(N9DH%R>$2JA6UU_13C1<065=$RI$E%77 MW_"XSE^NQ;GR&A1?JD'1I6H47JS"F0M5R#]?B?T917"*2L4LIYUX:Z$7>@TT ME6*HZ[V&CT]TE$WD3;:B$.BC&&&R#:_.]D#/ M >9_60II/R?M51W\_18$[YR?1* MYO>Y6%6/0]GGX!.;CN6>L>B_+@2OS?/ _:-M9,$5*HRBBVM%%3EIK]T\Y]W8 ME7):YU+8#CT4<2<*81N6C%D.N_#QBD#Y<:'/,,O6=A7];WYU\($QMGAVF@O> M7^HKA'>KW$=(TDD/S34]%--A&(9A&(9AM(NNI9"@.2O]=]3,?K;;;CPVTPF] M1EO@F;F;Y.KAYH/9?SAO9RG4"%34A<0PK^0R#N>4($)<\"7N>_&Z$,.^8^UD MHW5=7"NJHOK:7 ^,,P]#V*%L%%1!_-A^O.8YAH'8FGICB) M^BEP2#TC.N9?F^>.%V:ZRDJNSTQUP3/3?ANT,OC\C$VRJ,\T^V@X[DA!0F:Q3$NF MHC+Z/BZ&81B&81A&F]!"3F+V.;CL/H:Q=I%X:9$'K".3;UCU\T:Q)UII['"+TXVN)_J'(W)3E'RUU@*#13Z$D W1%91&;8?S,$B MU[UX>;9[6QJIN@W=:67MF:G.&+!N,X+W9^E=GDC@Z":FYO:I^:78!*RS6] M'Q/#, S#, RC76AN>K:\!FEG+B#BZ"FYZD>]!)M:;JZ=&]4A(8G;EUDD!"\' MWO'I2#E=BL;FEK9,MAO/5>G7J!(IK312NJC__DSY9]#J8?F?K%)2\1F2T?B, M0KG*&9V6CZC4?/EK+(4&COP:T-2,X'U9^&)U,.X?9:MZ&NE=0RUE4W>JA&H( M4OA+VJLO-8@'D:J44K$>*A9S2CP([9%_O@+YXO^C?BZ7:QIE25YZ>!B&81B& M81BF*T#S8@$!Z.60EE]29R3 MNL9F^96%Q(^JU?X4-:U!::(DU/1[Z:L*PS ,PS ,PW0%:'I.,DBAQ%2=I=# M:94@R#12OYATS'+<*=-(C54*VY$KAB)(FJ_]XDO)+X-$D/<.,@S#, S#,,P? MPU*H$:B?X>Z4T_@NX #>7N2MZK6Z4TCA8Q,=\=FJ0/C'9;)4,0S#, S#,$P7 MAJ50(URHJ$-R[GG8A1_%ARL"5+U6MP^VP$-C[/'!4C]X[TUG*608AF$8AF&8 M+@Q+H4:@GB29A66RDN:G*P-5O5:]!IGC[R-M\,XB'WCN/L%2R# ,PS ,PS!= M&)9"C4"-UD\6E\-SSPE\MBI(72D<+*1PE"W>)BG@\QPWR@;O+W8!QZ[C[,4,@S#, S#,$P7AJ50([ 4 M,@S#, S#, RC!BR%&H&ED&$8AF$8AF$8-6 IU @LA0S#M$//)/7BK&]J057] M%937-.!B5?T?QH7*>I16UN'\Y5J4E-?B7'F-9H)^WM**.GD,%\0Q_/K8+E4W MR&))<-#9?18LX-SQL,0S#,,S-PU*H$5@*&88AZ'F\?OU'-%YI05E5 PHN M5,FQ(;W@$DZZ9^@<73/0:WBKT [11A\\%1\0D%$LT].Z"NUIA?3RKJAM MQ#DQ(4X]58KPI%PQ<3Z*91ZQ&&T6AJ$;0A4_IUJ)V4Z[L/5 MI"%:E35-1ET MFB%-5DA>RZH;Y'7<=C!'"M(TVRCT7QN"_WX;A ]7^..#97[X]U+?/P@_O+?$ M%^^*9_H=$6\O\I8M9[03WN)G]Y7'0'&C8Z1S\/$W_OC\VP ,$&/&"+/M6!>8 M@.BC^<@KJ9!IIHU7KLKGPUBYUK;"3)-_^EA46E&/\Q5U,DHHK5BEH'-_N:91 MWLN&>/YIW*0QDSX>7*JNE^G*M.I,'X_.7*ALBRJC"#IF^OC4'L7B/)R[W)J^ M3?<,I6C3N3+D<;.SD.B2 %/K+[I7U7P6.#K&^8K6>XO.>VWC%3%&&=[X8$RP M%&H$8Y1"2A.;:K<#/0=NQ&T#E#W&?\WSQ$+7O0C9?Q*YYR[KY?B4H#V5\$K+ M5535-\G!-?]\A4RK2\PZBUTII^4]L\HG'B,W;L,;\SUQWTAKW#G$ MW[F^KD MV3>T>'FVNQ2KG+/EN"1>1(:69DC7E"8IM%>0)J>4&KD_HU@^BRN\XS% R/P_ M)CFAYP!3W&:DU_#WPP3=^F_ [4/,<,](*WPD)/&[H /8FIB-?>E%^3FBDD]A5^II<:\4R'N&[AUZO]![DX21QM!V4;S>=GZU1F5=$TZ5 M5,CT>CI&?6>S&%O0O4792T?SSB.[N$S>5Y=K&N0J=7-;=@&O(.H&ED*-P%*H M[#%V%2FDB1\)(@%>+&J04ZDO?>F8UW 4RTBA37<8M<$7MVF@ON M&6XEA;"; 9Q/PPH3&3T&FJ+78',\.=E)KJ0.W[@=$ZTCL<@M1C[S) &TXC2-$E\3Y=6BONH&/YQ&5@?F(#YFW:+L6$GIMCND/?4.(L(C+-4/Q:+ M\VZVY1!V'#DEI5Q?T+-%0D@20RN!M+_6:R]];(D3YV:/>-]$88(X+V/%>1EM M'HZ1IMO;(LR(8CM&F87]%*/%.V2L13C&B^M(SQ"=H]GB'EKHLAN68ARE#RY' MR**WV^AY@4MT^0]3U)-[PP9"F4U[2I!1D%E^!$UU.\,%^=ZZ'WC=CCA5(,:=6J=77#<.Z!6T5F#;2M,E-Z*%5JC3]1*.ZC%"& $7AV MFC-N'VPFQE+=?PRB#QE??!LDGSO:VZS[<]/Z 8VDI::A6:Z:'LH^!\\]QX7X M;,<#8VW0>YCQ9D]T-GKTWX@[!IKBG85>F">>)]K73/O5*[0 M-I)E'G'XSS)_/#+>0>_GUUBC_;[Z:)D?UOHG("PI5[X+:8Y#^UIIWR<]QUJY MK[0(2Z%&8"E4]ABU+H647D$K2514PRXL6>X5'+9A&]YL*T4U,.'H/M<#[2WWE2@<5YZ%G MJ% (0JT>4QJ5@HZ!9.?@R;-M*X,',,=I%X9NV(JWQ.3]@=$VZ#' 5"_BHT\I M)#FA?8+T;%$ZO5-D"M:)">="UST89;H-K\WSD$)(*\MTC^C[/M5"=._7.H%_ M8J*CS$(991J&1:XQ,-VF^N) M!T?;X9X1K7L%Z?KI>W WY#!D*=PI)JUT39^;[HJ'QMCBSL%FXO[GU0NE@H3H MSB'FN'^4-8;\L!4.$4?EA/!B9;V^+_U?AO8-QJ<7R>)<0W\(1=^Q=E($[QEA M*8[93*;4ZDMZ]"F%M&I%$TE*75WA&8>W%WCCT7'V8LRTP;TCK>3]0/<%"V'G M@E+7>PXTDQ]:Z-U#[Z G)SK)0E##-FZ#3VRZ7#G4 BR%AA-T7_4:9(X^PZQD M_0-Z#SXC)/'K-2%RSA9V*%>N'#+JP%*H$5@*E3U&+4FAK!C8?%6^8-/R2V4A M@!^"#V*X>/&^/M\+?Q]IB[]]O;$U#&!0-_0P-"FDZTM%#G:GGL9*GWWRFM(+ MD9[#;FU[Y/1]SKI6M)[3EV:Y8JQY."Q#DQ!WO$"NOM->,ZU14EZ#P]GG$!B? MB>\"#\ATR!=GNLGQ@.X?0[B']"&%E$*;650F5Q<<(U.PQ#T&GZ\*$O)BB]OZ MT8KI1H,X-UTENHESVG.@N=RW_N)L-TRWCX;WWA/8GUZ$O)++LG*IH:[PL!0: M:K2.7W<,-L+9^NYZ9OD)'[!ICWR/4M[PPQUY9"ET)##1.Z#OFN8 M%1X8;8N7Q/N;GN=EGG&(.'Q*?E E,624@:50([ 4*GN,6I#"]MY)5"7O0-99 M^?S0/K/[A @:'JJBWSQ4658?9\C8P@I M!F+"\!E+SS,O6O4?8Y-)SGBZ50.T$?=>X2XQSM9?W6=Q^V)N;@:%XI+E34 MR?F2 =U6FH2E4".P%"I[C%J00OKZ16DWM!=FC=]^]%N[&2_,=,7M@\WEES/> M W-KH6\IE)40KUW'>3&A#]R7B>EBXOK^,E_<.]):/'OF+/LZ"Q,IAK1OY>59 M[AAM%H;@?2?E6$M5?:\;< ET6EVFF>A-R:)Z^$: MG2I[ 5);$GUG:/P2ED+M!,U]:)Q[;((C_KW$5[:RL P]C)U'\Y$GYG+:M4KC(&QY[6 IU#0UJM%I!/<9HG]D/08GX4+RL[AQL*?=LZ'M0 MUGKH6PJI-UYM0S-2Q>2(^L;=/\9&%FM@&=1/4+_'V\68]]),-VP(/BBDY;+L MC66(_=9:6RO\*!O24V-Q6F&F]P&-U_H^CW\4NI#"^J9F^3QO/9"-$2;;\/@$ M>_099H%N_3> TT3U%ZV3>%,\)^X!ZD-'^\&H,BF]XPQEM9"E4'LA/SH(.7QB MDA,&?[]5SI-BCA7(#(KVAO=,YV$IU @ZE4+QH%$UL=?G>\IKQE*H.^A4TX2O M\&*U3']:Z16/K]8$X^G)SE((61S^>NA;"FE?#?7T.57 M+]&^HD%?GD>;A<,A(D6V=3#$HA@TV:&"'5E%9;#T:I+Z.A[*LTUJ 56OKP0I5P:65GFEV4O$Y5 M=4WR YDA>"%+H?:"WI>WB7&;ZBJ\-,L=_==M@=F6)+G5AEKS&.+XK058"C6" M+J60OKY0SO:_YGK(B2M+H>X@02DNJY'[S#8$)^)=,;FY>Z@E>AEH6I@60]]2 MF'^^$CXQ&9CIN$L6ENG&HF\0T5L\9W1O#%J_%;ZQZ099B93ZOIT6]P\5Q9EN M'X6[AUO(L='0/RCH0@JIGJ%,,J QR_M0!+H4:H::""(S4(VI>% M+]<$JWJM>LC>0Y9X98Z[;/#,4J@[6JY=1T)F,9X=_S76'24BBW,]+8DC[ MU R%\NH&[$LO:JU"_%W(+U;"]'_^_BC4DD(2"FH]45I1)]]57ZP.QC\F.\F" M3?H^9HZ.09-WRD*BHC^T?Y?F@_3QLZI>_Y4C60JU'71OW3'$ F_,]\18BW!X M[CDNB[C1%@!.(^T<+(4:@0H?4-I9>%*>;$F@YK6B/0!W#+:0O:Y'%RCJ$'LS&X!^VR,;95 !# MW^>#HS5D.7TAAM38?J[S+OEQYFQ9C1Q[#06:Z/C$G,!DFQURE9G2CO5]WFXF MU))"2J>E:T3]6ZD2X;/3-\G)(;W#]'W,'+\-6KVEZ_/\C$U"X(-D_\ASY36* MW0^W"DNA]H.>>2H:]N1D1ZSPBI6%N!JO7#7(O>&&#$NA1I#M"1J:L3OU# 9] M'ZKZPT6%%UZ8X2JD,$UO.?_&)(5439 JLAW-.X]OO./QM)A$]19">!NGC2H> M^I+"\Q6MU]=JVV&\N]A;3)!XKY/AA8D4PT'?;X%S5(I?<\])Y!ZZ@+*:_0_ M?FL)ED*-0!-72C_;+P:OH2;;5+U6+(6ZAR:>M$^()GP#OMLB)S<]!IIQ81D5 M0E]22%\N?6-I+^%.O##+%2R$AA@F*D&E(U"=4WU#%4">^,M=#]L73][%R_''0/4NIVG<- ML\ DZPCL3CF-L^(9(S'4%RR%72-HOD3SUQ=FN@DQW :K[4>047#)8*K<:@&6 M0HU!5?%H,ZV:UXJE4/?0*B'MB>F_KK47(35HU?< VU5#UU)(?SS]';07;(5W M/#X3D^-')_#$PU"#)A;46^WU^1Y8%Y @"WSIF\;FUNT#-($>*<;_[OU:JSKJ M^US=;"@MA?0\4?8,51G\+N@ GICLC'O;/J3I^U@Y;B:H1ZB)3"%UB$B6\YH+ ME74*/"FW!DMAUPK:4_RPN(X3K7?(A13:5\AB>'.P%&H,ED)EPM"DL/!B%;X7 MDYL79V["0V-M>7*C8NA2"NE%1'L::)5G<\))V4_IZ2G.Z#.<"V$8:M!*QMWB M^CPJQ'"QVUZYPJMO2 @IS8[>H5^N#M9<(W:EI9">)^HEF91S#O,V[<'=(ZQQ M^V#N]:F=:$V=_Z=XWPTS"85-V!%D%NIO18>EL&L%?53O,\P20S>$8D_J:?D! MR1"JW&H!ED*-P5*H3!B*%-)+D*2$!&6!ZV[<.<0,/0>9:B8M3(NA6RELG^C$+Y MC.GC.6,I[%K1K7TE6HPYU.^94I.;#:B*M"'#4J@Q6 J5"4.10IKV/VMQ9ZZ_W\=#:4ED+:@YURZCR\]AZ71258"K49O0:; MH<]P"[E:&'/LC-Y:"+ 4=JWHUJ]5#-];[ /;L",RR^*B'M.3M01+H<9@*50F M#$4*J8'O7O$R--UR")^L#)0KA#S!43=T*874=_*,F-#O3R^2$_HG)SGI_?@Y M;B[H6?SOZF"X1*?)*G:7JAI4NT_^#!JC?&/2,=MQ%UX38Y>^STUG0VDII-31 M^/1"V:^1>A/RF*G-Z#Z >A>:HO^Z$$0GY\LJW-=8"CD4BI=FNV'!ICUBGI,\(Z[:PPGVC;&05U(?&VN&QB8YX%4^)^T1)P'AJN M7)55UG7-P:RSLL\E?01ZIJT=%,=-CL-B[D"])VD>(4.\:WJ*>06]=VX3X['L ML]Q//Q]MGICD)(OW?1]X0%YCYL]A*=08+(7*A*%(X>&<$LQSV2V>#UGV47CE3DLA501UFK; M$?03$[YGIVW2^_%QW%K0QRL:J_[[;2"V'\I!34.S7"W4-4?$>_C[H$29BDQS M WV/:UH*&H/IX_$];1]CJ4@7?6"^0PAB3RF&9K(HEC[$D'Z>%\4\=HQ9F/SH MP/PY+(4:@Z50F3 $*?Q1MBDHE$V7:?"Z?;"Z;2ADJH[L#V6%?PCQ>WNAMYCP M!N#+M<&R6?<(<5^-,P_'>(L(3+",P$3K2$RQC<)31?IH[2/C$U[^_:QF:Y%VRR[0Z\O<@;=X]0L>KH MUVV%&\;:B(FR,]Y"'W^B*SJ S.4:D8+^[?EV;I)J. M)NRT DN5_.A#PO/B?4"IJW0?4[&;S@2-+8O$>!L0ER$K+?]53IRYA)7>^^3/ MTU?\;+HX'W]K*Q!%JQ_T?J1QE)[GKA14%;F]BJMNBF&U?L3Z<(6?[ E:0!_J MZJ\H\,1TCBSQ?/G&ILN//U/MHO0^MFDI: RF#YY?K0G&5VM#Q'@<+"0_2+YW M/EKNCP_$V/S>8E\\/]U52B3=8[2*J(M]]22F#X@Q_-,5 0C>EZ7S^TJ+L!1J M#)9"94+?4DCGE$HDT^9Z*IO<6TSFU6M#T5K8I,<@4]PWVAI/37.1C;E=H]-D MKGU84BYV'#DE16EWZFD9>]+.8*^(F&,%LK]>8M99).64&&P<$#\?3=KIYZ6? M>\\?Q"'Q#-'$E%;Q6E2N2%95WX1-.]/P'R%G_YCBI)KXRPG<5Y0NXR@G6-/M MHV 7GHS0@]GR"SQ=8_I22M>9JEAVE:#CV7(@&Z[B'*_VVX^/5O@KFD+:9[@E M'I_D@#$68?)9U1MP*0_Y50IYCCMEMD-=^NDO4OK&'J;$.7;Q3A- M$TU*,WQICEN7BA=FNF.^)M?X)V"O&;^H]J6NH;7%4).M\F.)OJ"V&!N"#\K4YZ>F.*LZ_O<8:"ID MT%R.%\],=1$3=A\QH8L38G=:W%.5LF*ROJ&T>UKUIUYD-':J_3ZD9Y?.QZ/C M[?#T)$>\*23FJ[7!&&&VO4O%X U;Y1Y-*HCUX&C;MI5#<[EBK.8Y?F[Z)DRR MWH%-T6DXEG]!W[<7HS"4D4,?AI9[Q3H>_3H E8"C4&2Z$RH6\II%7"YI9KV)62+RNOR4W9*DDA%8ZA M+\ TB5GF&0N?V'2Y/ZI63.Y(3/79?ZVK0U)(^PD?'&,C-^ KV5R[-;W/5%Y? MJL"XVGKH12A>+')SJJ-/:WKH:1_'RXW%>N-M/JC4O4,3%.G4%>6V$F?>SY M^C6'L\_)5%I:<:"4>+7>A;22+K4F8[;0+GW\;A'_.=)5CC%KGF.*QB0XR[9#N\0.9Q?J^O1B% MH1Z!-,^BC^#^<1FPV7X$,^RC\8:8A_49:BE7IM6XKU@*.P]+H<9@*50F]"^% M/\K)+*5L]EL;(M.2NJOTM8PFD5^OVRP;7\<=+T!C6]HDNZ#ZD*RL]=\G)I86 MBO>=E:B/M$R8QIHEN5PMZ)]'U MIM5@2L.GBIST,5&]#Q&M085*7IOO*?=>Z_,Y8]2#Q@^:=S2*]Q/=7[O$=1YC M&H:'Q]CA+B&&:MQ7+(6=AZ508[ 4*A/ZED):H:.)173R*7R])E@E*6R5D%?G MNF.Y5ZS,^<\]5R[317EU4%U(5"AEAIJ.T^HLK6@HO;&>]GL]-]T57Z_=+-L5 MT*HD3>R,+1V8CIPQZ#323Q4"46#&D+]BTWY?2-J/$LZHO?BF% M#X]3I[ *%1IY:HHC!J[?+,;]%%DEM*Q:W3Z>MXHNI)"N^^,3'/#I-P%PBDS! MN?(:N1]2'WWT= E=;WH_Y959D41G<=A[#9.M(O#K'797[BJ6P\[ 4:@R60F7"$*205G2BQ$OW MJ]5!Z$Y?Z;]6NAH7??G?@(^_\9.I3C2I,83]0,8 "?_%RGJDY)7*ZJV]5?@2 M2A4AOU@3@E6^^V5:3J,1[P^E,8KV%:[TBL==U#-KH#+M*7K(L=!4ME.@";*^ MT(44TFK0YZN"L,H['G''"^5'C6:946!X]Y0NI)#:QWRPS ]SG''*^- M(=V>CH^"KG]953UBQ-BRPC-65C)^0J45PW8II )H+(5='WJ$J!T4]7ZE@C14 M0$N-^XJEL/.P%&H,ED)EPA"DD%+>=AS.PY=BPDE"J'0E+EDY<:(])EJ'(_;X MF9\F-8SZ4 H6I9I1\9-I]M&RR;J2UY;N%2H",D<(9ZAXJ5*:G[%?VY+R6GSK M$X][AEG*\4N)_9NTXDB]MCY?%8A(/?:Y4EL**>7V7W,]9#/XH/A,Y)PMU]NQ MW@QJ2B'U4Z/GBWHK4GL"KSW'<>RT\14_(3&DCTSY)9<1M"\3"\6]0>U(E+[W M*$@*7Y[CAG%6X2R%1@*EI%,J=G+>>=GZ2HW[BJ6P\[ 4:@R60F5"WU)(Z6X- M32URHOGEFB#\[>L-BDLA20/U#3().8BT_%*#VA/4U:&7'344:OS:/ _8AB>C\&(U*NN:C':5L!V20BJVHZ044EG^'N+/^6PE26'7 M7"GLUC;FTRJAQ^YC,FVTO*9!;\=Z,Z@IA73?=!=B^/8";]G6I36-UK#/AUJ0 M&-+80JE^U.=MR ^ABI[K]F I-#[H(R9]/*7*RM/LHE6YKU@*.P]+H<9@*50F M#$(*Q8!(:4G46/QO_39 Z3UG[RSRP1(QD:0^;OKH_63,T-ZC$^+^#4DXB=%F M8;A#P95"FK32'M3W%GN+B1KW7B)H\GJVK!JK?.)Q]W"20F4JO9(\^T'<^1831_4 MC!4Y>6]JG[RKLZ+#4FA\M!<(HU7XZ?8LA88"2Z'&8"E4)HQ!"ONMVR*>N>-R M7UMYC7&T)S 4J HHO>P"XC,Q2A4I-,5[0OKIZ[VQ0^,335RI^BH5]2$AI#%, MB4(SH*84]J+C0$$M\ MM3I$K@X;>X9%>R&GC,)+F.FP4]%SW1XLA<8'2Z%APE*H,5@*E0ECD$+JX[4_ MHU@*(>TG9'1'5?T5I.:7PC]%?O+^-79HTDZE M]//$<[Q /--*MJ1HW5]FBH^6!W1I*:0&\*/-PG'HY#F]'6-G4%,*Z5SH;#DG(QQCREMJF\])[#$+0;_7N*KZ#,D M*P)_O1$?K]"O%"9FG<5\E]VR;<2#8^P4'^]9"G\.EL(;0^_)V4Z[%#W7[<%2 M:'RP%!HF+(4:@Z50F6 I9-2DHJ91RLJFJ%0,_F$K2Z%"4)71*RW76E<'SU[& MWK0"V&Q/QFC3,+PTPTUQ8?J;[!]J(J30'^&'<_5VW/O2BV1J['/37>0$6NGQ MGJ7PYV I_"TT!\@YRU+(* =+H6'"4J@Q6 J5"99"1DUH%2LQLQB.$4&2B/>X:9JGX>,]2^'.P%':$/LPTMUQ#>L$ES%!I\LY2:'RP%!HF M+(4:@Z50F3 \*30!2V'7X7)-(_:G%\$V+!D#OB,I5+!/81>60NJ))B<+XGZM M;KB"<^6UR"HJ0\SQ CCM2,4\E]WX8*DO[A(RT+W?1I4D\+?QD=Q3J#\IW".D M<+CI-CPTW@Z]AREW+[6/]RR%/P=+84=T,7DW!BFDU'>:2]$8I^7X4:$)(4NA M8<)2J#%8"I4)@Y+"-<%@*>Q:L!1V'AIG2 :I2 ]-%+8F9LOSM](G'E-MHS!@ M_199??/)28[H-=!,9T)(P5)H6+ 4Z@Z60F6@\TC[H6F,TVZTR'3^ZPI,"ED* M#1.60HW!4JA,&(X4GL(7JX-5N8XLA?J#I;#S4!-Z$L+"B]4(C,\4SWZTE,!' M)SC(B7I/(8(]1'17L.7$S09+H6'!4J@[6 J5@5+A:QN;9;LB;4:3#)JWT#WQ M5V$I-$Q8"C4&2Z$RP5+(J E+X1]#*4@D@2U7K^-"19W.3'-%[J+)[Z#H;/_4I/*R_EA0LA1UA*=0=+(4W!XUI5Z]=E^?J M4E4]4D^5R@])P?LRX;GG&%RB4V$OQC?;\&1-AIWXV2D<=Z1@4W0:W,1\_E;" M8_+\QTE7/Z6XE7YKCC]7D>>'.^)]Z:[XV79[HKWTJH+5@*.P]+ MH<9@*50FC$$*)UA%LA3J"9;"CM#$DGH+7JBLEX5C$L1]N2LE'Q%)N;#>=AA? MBF>@MQ# 7@.5J]*J1'23%4U-60H-#)9"W<%2>&-:LQU^E&FA9\MJQ#U9@MVI MIQ&:F V'B&3Y4?;%F6[H.]8./092O0#E*XQK,6@NUVN0&>X8;(X[Q7OQ3B%M M/54:]UD*.P]+H<9@*50FC$4*$S*+I:#0!G=&=[ 4=H3NO].EE3B0=5:FB$ZV MCL# [T+P]9H@O+?8&X]-L!:7EJLQ\.%-:B2,Y)5@?> "OS_>4*>^T"J9&-7&.S@=+8>=A*=08+(7*A%%( MH56DN%_.R8J.]!)C=(>Q2R&E4\6?*(1O3#K,-A_"8K=8C+.,P!=K0N2[H,\P MR[:503HFPYT\T1=LJGCZV:H@1'"A&8.!I5!WL!1VA#YXE5;6X43!)7CN.8$Y M3KOPR@3?F>>'O M(VUE&I6NWC=*!0DA%;OYK+(4=82G4'2R%/T-SH>J&*\@HO(30@SER MB\8](ZSD.-&MO_['*XZ.P5+8>5@*-88NI)"^X-\UU%)6B7*-3F,I5 &6PJZ- M,4@AI5%1!='+-0WB6;T@[N4\!,1GP#$R!4L]8C'H^ZUX8[X7'IO@B-Y#+.7$ M25?O&Z7BKF&6>'2B@Q"F,.P58J8O6 H[PE*H.U@*6Z%V$_3.SCE;#O?=QS#9 M)A)O+_(68[NY?(:Z&=A^: Z6PEN!I5!CZ$0*Q>3MGI%6>&.!IQS\6 J5AZ6P M:V,,4DB3)&HIK8UG-?BE_0'QMC* MCV.SG7;)BJGZ@J6P(RR%NH.EL!5*&Z5Q/>Y$ ::)>ZB%P17'XO@Y M6 H[#TNAQM"%%/8<9"8G=&\N]&(I5 F6PJY-5Y-"V5=0W$-UCY7U#NK='49,D$/81<4"K88Q,=I A20V7J,[;, M,Q8^,>ERA4!?L!1VA*50=QB[%%YO:TI/U9,I&V*-_WXYUG7O;]*V)YK#4(.E ML/.P%&H,74DA#=)O+?*&QY[C+(4JP%+8M>EJ4D@3H^KZ*R@IKT6LD$$[<5SS M7?9@H#BVMQ9XR?+K]X^V^44!&2VE4YF(G]4$O8>:XQDAM1^N\,,,AVA8;3N, MK8G9.));@J)+U;+:H+Y@*>P(2Z'N,'8I;+G:FC8:"QFZ50#5@*NS9:ET*Z7T@"+U;6H>!"%3*+ MRK _HPAAAW)A$G(0HTS#\/9";_0=8R?[36EI5;"U]^!&(8&60F1M\<0D1[PP M:Q,^6.:+T>;;L<([#IY[CLMV+E1ROKZI195SW!E8"CO"4J@[C%T**VJ;Y"KA MIN@T,4;XR?G1;0.T,]X9<[ 4=AZ60HW!4JA,L!0R:J)U*:2)4)80P;UI9^ I MQH#O A(PRW$G!G^_!>\+>7I^QB;T'6O?VIBY?ZMDZ>I=HL3Y(Y%]8J(CWE_J MBS'F85CENT].^K8?RI$R2,=>+ MW/;*>6QK41G]CV,>I MY/KV0[DPW7)(]KM\5XP%CT^TE_MHM-2#JUM;@1O99F>PN4QO?6"4+1X=YR ; MTI/H.D0<1;RX5D67:J0$&B(LA1UA*=0=QBJ%K:UVKLM^J[2/\.MU(7ADO+W> MQS2.FP^6PL[#4J@Q6 J5"99"1DVT((7T7%^7$[ZKLGA,6GXI=HC[<5-4&M;X M)6"RS0Y\N288K\_W%$+H*(NP&'JS^5]'NPQ2%5&JBOKYJD!,LXV2*Y]N.]-D M0_K#.24R1;9*""%5$6 H[PE*H.XQ1"FE<;&K[2.8;FR[;ZSPW?1/Z#+?2 M^YC&Q4'!4MAY6 HU M!DNA,L%2R*B)(4HAW7.-S2THJVZ0*V/)N>>E(#E%'L6W0I9H9?"3;P+QM)@ MW2>$D";'NGH__/4PD=(J4T2%!#XYV0EO+/!"OW6;,4-,9-M7!J/$A#.S\!)J M&Z_(9X)6!+0 2V%'J"+L%-L=XCUEC3N&*'N?LA1VQ!BED,8&JCA,8^02]Q@\ MS&FCF@R6PL[#4J@Q6 J5"99"1DT,30KI&:;[[7)- TX6EV'OL0+8AQ_%./,P MO#;''<]-<\$CXQWD]8.[PP$ VG*=*HI9M MVB-7A.\9::WH^6 I[(@Q2B&EEE-6P4J?>'RV*E#<#[R74(O!4MAY6 HU!DNA M,L%2R*B)OJ60KG=-0S,*+E8A]G@!7'>F8:G[7@QXG4RN?G;9)IHEJ MK\\@A0GN$1.U)R8YR=YA,V6S^22$)&0)^3TK)["G2BIP40AAHX$6C^D,+(4= M21/7=X&0PF>FN8A[F*5038Q1"JD_JWUX,OZ]Q!=/BC&&TM+U/>YQ=#Y8"CL/ M2Z'&8"E4)E@*&371E10&[\N2?Q^E0OY4'.%RK;RGC^:=E]5$S;<>PD3K"+R] MR MW#;60%42UU%>P6YNT]AQHACN'6J+O6%L\-\T9[R[R1O]UF[%PTU[XQ)R0 MQTO'WA5A*>Q(6OX%V3?NV>DN^+MX5REY/E@*.V),4MB>89%_O@(K/./09YB5 M'+O5_VC6NB>:QF7ZN^B9[(KQ<\$RW52P9BGL/"R%&H.E4)E@*6341!=2^-Y" M7RF%)(176JZBMN&*+(Q X^Q:__V8Z[(+H\VWX]-5 7AUKKOLL47/MJ:$4 2M M9-XN)NH/C+:1$C#*=#O,MAR"IQB;Z/F-.5: ](*+**VHE>FR71&6PHZP%.H. M8Y)"JD9\J:H!2=DEF.6X2]X+)!;J51TUD5D/]*&.HL= :J%C)I_QNX99=J&P MDGO5>\FM"AM_T=I(73ED*>P\+(4:@Z50F6 I9-1$%U+X[D)ZT:7_5$#F7'D- MO/>>P- -H?CG#!?<.])23&:TU6R^/=H;SO<:*%[J0RR%$-KBQ9FN^$P(KF/D M411?JD9#4XN ML!1V'I9"C<%2J$RP%#)JHJH44GJ1B*'&,K>[CIXFNL&D'5_EZ>XXXOUP3+*J+44L(R]+!\A] 86%G7*)ZAZYJJ M(/I78"GL"$NA[C F*:P4[TJJ.AH8GRGG66JN$-**X!.3'&1:_W"34"QQWRLS M/-8')F!#<*(,DY"#72:^#SH@Q_'EGK&8Y[P+_=>%X/&)CJJ^1U@*.P]+H<9@ M*50F6 H9-5%7"EN?ASY"#IZ>ZHS7YWO*R7'?<;:X=Z25+(K08Z 9NFNJHFC' M^.=,5PPSV2;31!,RBW&AL@YEU?6H$#)8+U<(KVNZFFAG82GL"$NA[C F*2RO M:<#AG!+9TW3 ^BTJ2:&)S.#H,\Q<5DRFXI9P44P-O76[@5^Q8Q,]\]P@K^7Z@TN_]O]N,$6)\6^89"Z>H5-E/ MD=)BJ0"$,4G@KV$I[ A+H>XP)BDL%=*R\VB^7-7Z=&6@*E)XCQCOJ(7.5VN# ML=PK#GZQ&4C..X^:ABLR\^''+CK6M1X79)]8$L2]:6>PW#,.'R[W5VW%D*6P M\[ 4:@R60F6"I9!1$S6ED*+;3X4)S.3S2JN"W53>GZ%TR&I[(IZ<[(A)-CO@ M$IV&K8G9V)=>*/O0Y9^OQ$4Q>:#GI"M.DCH#2V%'6 IUAS%)8>'%*BEIU.+F MK87>JASK/Z8XR?V*MN')V)UZ&D67JE$AWM$T)S"&<>[JM>NRH ^=:_KH9Q&: MA$]7!:IRKED*.P]+H4:XUE9A,/Y$$89L"%7U6K$4J@]+8==&;2G46I#\]1QH MCCO$>7AXG#U>F.DJ>R6^M\0'8\S#A!"FRDEG<5D-ZIN:VR9(^KZ*A@-+84=8 M"G6',4EASMER6&\_@G[K0O#<]$V*'B-]P*,*G&\O\L8/P8E(/'E6%LPR5FC% MD(X_^FB^&'O"5+FO6 H[#TNA1J &S)3O'G$X3PQ8FU6]5BR%ZL-2V+5A*>P8 M)!XTT28A_&I-"%9ZQ\,^XBC\XS*P*_4T,@HOR5+P5/V/G@UC3Q?]-2R%'6$I MU!W&)(549.8;,3:].M<##XVU4_08^PRSQ*/C[3'X^ZT(VIZI2RJBQE4"/0X$'+[4'[LO#%FF!5KQ5+H?JP%'9MC%T* M232HX WUJ+IWI WZMJT._GN)+U;[[D?L\4(47*A"75/7["NH-"R%'6$IU!W& M)(5'\\YCND,T'AQK*YXS2T6/D=KJO#+;#;/$GY^04:2W8S04*(V4YD#T+$^S M4^>^8BGL/"R%&J&J_HK<8^,7EX'_?ANDZK5B*50?EL*NC?%*(16ZV2 FZM:R M@NC'WP3*_3-+W&.QR2W! M9)O(GZHX*WF,3TQRQ"??!&"UWS[Y]Q@[E W2W'(-Z067,$.E^XJEL/.P%&J$ MBMHF*2_>>]-EE3XUKQ5+H?JP%'9MC%<*-Z!;_Q_P]%1'65UOJ4=L:W6]W/-R M_PBE#/V<'JKOJZ0=6 H[PE*H.XQ)"@_GG,-XRW#9X[7G0&4KCSX_8Q-&FH;) M C,D0L8.S2NIVFIV<3EF.^U2Y;YB*>P\+(4:@:0PY^QE>.TYP5*H0+ 4,FIB M#%)(Y=J[B[ASJ"6>G.R$-Q=XX'",'3Y>$2!?[%0\9D_J:3%I+Y5[H,NK M&^1^:"I!3GM(F%N#I; C+(6Z@Z50F?AD9:"L;)J852S[(3*MT/R+I=!P8"G4 M""R%RAXC2R&C)EU+"DUD2XG6XC$6N'^T+9Z:XHS7Q#-$$YTQYN%8%Y @*XDF M9A;+9O,D@BR!RL%2V!&60MW!4JA,T'L@>'\63I54H*J^26_':&C0_&N.\VY5 M[BN6PL[#4J@16 J5/4:60D9-NIH4=N]O@MY#+<0$W ZOS_?",)-M6.$5!\\] MQ[$W[8RLVB>;S5?6H[ZI1=S?U^5^$4896 H[PE*H.U@*E8E19F&(3R]$=?T5 M?A__ I9"PX*E4".P%"I[C"R%C)IH70I;1<%,]M:Z?[0UGICD('MW?;0B4#R3 MT3#;<@@1AW-QNK12%H^YQ@*H*BR%'6$IU!TLA*CM'JF(RR%A@5+H49@ M*53V&%D*&371JA1VHW]^O5%,BBS0=ZP=7I[MAJ_7A6"FXTZ8;#XH*XE&'2'K7*_X+9#N<@J*N-]@GJ"I; C+(6Z M@Z50F6 IO#$LA88%2Z%&8"E4]AA9"ADUT8(4MA>/Z3787$ZLJ;GRA\O],=XR M LL\8F"^]1!\8TY@KQ"2C,)+4T"WHH M37@?&>^ 5^:XX\LUP7*RLM@M!C\$)V+;P1QD%Y>AK+I>%I!A# .6PHZP%.H. MED)E@J7PQK 4&A8LA1J!)IDLAS:Z%<*3610)=&> UN?Y2$K*EYK5@*U8>EL&NC:RFD2J(D@7>(R&.^)R;91&*%5QS6!R; /CQ9%H\YG%." M8C&&M%SE-%$MPE+8$99"W<%2J$RP%-X8ED+#@J50([ 4*GN,+(6,FNA6"C=* M(;Q;R,)8,:$)%1)(C>9+*^I01^TDVO8,&)9" MPX*E4".P%"I[C(8CA7GX8DTP6O>!*7N,+(7Z0TTII$EKGV%6^,P]U!*/C7? I]\$XOO ]B=JL"OU--;Z)^#M12R%?S4,3PHW@*6PZZ"F%-(D^&4QGHZWB$#0OBS96["Z M_@JO"'9A6 H[PE*H.U@*E8DQYN$_%?OB%D _PU)H6+ 4:H3\\Q4(3\K#-][Q M>&.!EZK7BJ50?5@*NS9J2N$CX^WQG^7^LM?@WK0SJ&]JD=>75P6[+BR%'6$I MU!TLA-:60&M%_M38$WP4>0%).B;X/E=$!+(4=82G4'2R%RL2 [S8C M)"$+ITLK4=UP16_':&BP%!H6+(4:@1ZJEXKED+UT844TAZ& MQ*RSJ*AMQ)46[D^G2U@*&25A*>P(2Z'N8"E4)KY<$RSGP,?/7)#O!Z85ED+# M@J50(^2<+4=@?";FN>S&JW/5E\*_C[9E*50174CA!*L()&04BQ=0@Y!"7BG4 M)2R%C)*P%':$I5!WL!0J$Y^L#(!-V!'QC)W%AHUV!P/C+'#>TM]X;7W!$NA"NA&"B.1D%DL!85ZU3&Z M@Z6041*6PHZP%.H.ED)E@J7PQK 4&A8LA1KA:-YYF&]-PM -H7AFJHNJUXHF ML ^.M<,'R_WA$Y/.4J@"NI+"_1E%**]I8"G4,2R%C)*P%':$I5!WL!0J$RR% M-X:ET+!@*=0(^\0$KT=HZ'! M4FA8L!1J!)*'H1NVX;&)CKAKF)6JUZKW,$LY\?QR30@"XC-9"E5 MU+(Z:.Z MYO]O[\RCLB[3/MZ?HUG9WMCFM%GSCF7;U-1;9M/T-I61HKGO2VZ8FDN96FXH M @*"R"8(*HB(@ L(B"BBXH:B**((HH@B("(JKG.]]_=Z?"Q<:M3?\CP\U_>< M[_',F7/B^?U^]W)][ONZKUN@4*2E! KK2J#0. D4:N.O?HFFB-4YM/=P.1=_ M$UDD4&A;$BBT80'&:B]>HJHSM30O)8<^&AU!#[7WH$9MW'3]5@^KO_%R/W]J M_<@EA(&SHI.U@=;T% M"O67$5#86DU"04D[:$L^TE7.&OZ,CBR!0I&62LDNI,XSXJAI3U]Z^!L/3<<) M@<*Z%BBL*X%";2SIHS>70*%M2:#0AG7I\A7*/72"8C/SR&7.*@8U([Z50*'^ M,@(*6XZ*H'$1:REATWXJ+JLV_!D=60*%(BV5NJ.0NGLLH^=[SV9@T7*<$"BL M:X'"NA(HU,:HT3!S:1:MSRVFTLK3ICVCK4F@T+8D4&BC HCAPO'4[(,T007V MK540^'0W'T.^E4"A_C(""E_I'\"[A6Z+-U).89GAS^C($B@4:2G<-SK0-Y%: M# ZF)EV\-1TG! KK6J"PK@0*M7&K,?/)-3J35N\HI"/ELDAKE4"A;4F@T$9U M10W$9VLO<@ZZDPHJ__9M #VB?\3YGVC+8F M@4+;DD"AC0D =OK<>=I=5$8)&_?1" 4N;PP)YGL#M0PL?\\"A?K+""B\KZT; M+R0X3X[A@C,UYR[0!?5W1?I+3RA\OI2B_T\F,@-.H[P0*%^LL(*+3ZG6&A-"5R/4-* ML:2M&"(]H1!GRMX<$DS]?590RO:#9C^JR )%-:50*%Q$BC4QJ@)\:Z:BX<% M)'.Q&9%%^245])U_$MVO8KQ[&0JU>^\"A;=@FFI[MZTR/?>!BV0VBU0*'^,A(*7^HSF[YQC:49,1O5I"=GT(R0GE#8 MV'D&-5%!U)<3HFCIAGUF/ZK( D4UI5 H7$2*-3&../?M(XG%P4%#94[ZB!QNU*H/#V91@4OM)_#F^;[S]:*;:ZQ.+-^XY2XM8"FAJ5 M2:W&1# (WM_637400((^H/!'@Q>^U]>3%BMH$BC40T9"H67"#::N[O$,^94U MM?RW4!A%K!8H_&]D&!2B0]S75GV@]C/$5XV!I[$"0 P^#144 MF+4S>,, WMHEWA MG#*^+0(ZBZ_B@T?+A6AL!0OB%WG[48=I2\HC-XB!!H%![81(X=^$2+5=0^,6$ M2/[^6N?3U[4K/=+!@R>CKR=%T]AY:VA^VF[:H(+-HQ4UO&IW67:8-!/."><> M.D&QF7G4W2.>TX:T_J98:$, ^V07;SY?.#X\G7SB-U.XFOP2-N7SA>< T]U% M)ZZEJM^N#QP]207*AXY7*= ][Q!!BRU*H+"N! J-DT"AML9U$!525/?'V]EW-Q&%W&U*\LYR:P^OQL=V_Z^W=SN4#4 +]$5_"/U$;7J$R:E[*3[\9< MDKFWWAN@EE-XG$Z<.LM7P>BQ^X64H&,G:VA+_E%R\5_%YQK^U%J_[PK@AYMT M\>) ^8-1X=1V&Y9./\]?2[X)6[CP%,X9V[-C,O8J M4+;X;MH1K@_"^&C99=<7E@4*ZTJ@T#@Y$A1F[2NA/E[+^6YH/5+^?SL/-_K: M,EXWZ^=/SFJL!B0%K-Q.B];MH>59^WF>PC$/J_&_\6X2LO+YV(FM&[]UY98# MU[Q,/=/2#7GDJV++D<&I?!Z^65]_72ZMMQICPYM#0JBWYS):D65>N[(G"12* MKQE;[3BCA)4K!$RHC(7@UBS59RBTY-7_AU*V'21G5*=4[QZ#HQ'?N8&3)84% M!850V B#YO^."*./%$A\_$-$O3=6@@-6;N/ \FC%:3[+H;7P;;'BB\J@/RBP M>J2]AZ[IP9QQ\-4TKEJ,ZL&XRQ"7W&/2_6O_.=1\0. =&T6G6@P*XEU(+!A] M.,J^_=%HU<['1%"K,7?7WG'%RZZB,B[PHW?1)H'"NA(H-$Z.!(58Q!OHETC/ M]IC%L9"N\_#5\?HA-5YCK,8B+?HW=L^PH-=U1ASU5_$/[J/]=E8B=?=((.>I M2\A)Q0M.$Z/5O[;K-I,7<_V"]JY+J,.T6.HX;2E#X&?C(OD9FZLY!872'FIO MN7)-KVRY%_O,IK:38KBR?^:>PZ:U*WN20*'XFA_K.)/OM.OIN8Q6[R@RNVW6 MZJK-S7K.YM:# [B!3D 8[-^<^@9]9O^W,6+GN@R4_UKNV[2U8N? M 7 -X'VNEQ^??<>S80?6B'D0L0W>&\8);'+D'38^SK-'"12*K_GYWG[TZ=B% M-&'^6DZC,%OU&0HA@,.V_:4T(7PM?30J@IY7 Z<9W[W!55M3$.N[FP\(H!]" MU_#"1X%.4&C]OI6G:\DG;@N],S24GE5@B(#3['[NZ-:JK?>?M9+6*R@\=E)! MH<[G<04*ZTJ@T#A9JT7N*2ZG07Y)NO1)6X%"%-;R7[&-NLR(8Z P>FRR5.E' M97I+)@_:-K(^8"S:8V<-63XPX,I6C6NP\ PX*P@0A/&;D8V&\::!SE!HC6F0 M_>2_?*MJNR=,/0IE3Q(H%'/G04=]6X$24B?"4G-L8E6EOD,AE%]2P<5 ^ONL MY/?/@YGL)NEJI%..4@%VRO9"#@+TK+I:??8"A:?NHK:3EE"+0<$\J9O]_&)M MW,]G!:W;74RE)VNXDK">$BBL*X%"XX5YB<5::E"(NUMT"A>1(H-%Z. (559VHI1\4= MN+Z@@VNL0*&=&JFJ352;0K$>U ZPU'"P@:#6#B10Z,!&JB( Y$V7$.H\?2D% M)FZGHN/FW4MXO1P!"JW">T>%K#<&!W/0AP/G9K>/^FHCH1 I*ZAPNO/@,?IE MP3K^V[P3; /O07QW%B@T3P*%QLL1H!#]N$2-U]@M'.B;R&?B<$V7+-+:AP'Q M#=5XAN(\G=WB^!JE/8=."!#>A@0*'=1<;.&KZ;PSY3PIAF8OWTH9*L IKS8_ M;=0J1X)"@$-08C;?5X0!3=\[DAS;1D(A*I#B+L2RJC,T*WXSO:&^;2,G_>YE M$AMG@4+S)%!HO!P!"I%BB&NX#ARMY'.%J*")-,1[#;HN2GQW!A#";28MIK"4 MG3Q.5)R6 C.W(X%"1W3K:?2 FOB>Z^%+[RHX&C^:V>"/?4=2DLS?O%LH5!MK;2"C$"B7.,^">+UR:WLDUEO[V;0!7 MDC/[/8COS@*%YDF@T'@Y A1:A9H*UP75-PD4.II;6^ZE>Z*C%_WKAP4T/, "1L5EI_BR M>ENJT.1(4(C52>P6;MU?2C\I2'^EWQQZN+VG>FY)(]7:1D(AA-U"_(VLO!+R MB=M,W6;$\_9)H-!X.1(4UM1>H$UJO Y:E8#@OA">SG/H*V-AD*KL/"R=E^-".-=8/FV]FN!0O,D4&B\' D*+UZ^POUZ5U$9W]O\BIHS<*1#%FEMS]@A MO%\!X1.=/?D:D4&^B12MXKKCZON);E\"A0YBZP'?C(_F"WT9M)#W87BU0:)X$"HV7(T'AY2M7>+<0::0!B=GTJ8J9GNOE M1P_*/;,V9%?V \YN]'0W+WK+)9A&!J?2\JS]?%F]+1V%LB<)%#J(<3X->?'O M#@^C,:%IM'1#'N675)K=_GY7C@B%.(-V[OPEJJP^1Z$I.ZCEZ'EJ(A)XT-)F M02'22"]=ND)I.PJIFWL:D[::#?2OK[=W--?Q_B.[- H7D2*#1>C@J% M>XK+*69]'N]"O3ML+CWZC8=J(Y)&:K8?;#>#GN[FK<;$,+X#&'/J]@.E7-A- M=.<2**SWGDH-G*:2\Y1HBEJ[FW85'>=<:ZRFV&+*Z&_EJ%!HA8>2\FH.TCQC M-U&K,>'J.PH4:F&SH- JI+4<4=\V>?M!ZCHCWO3W(;XS"Q2:)X%"X^6H4(A8 MZ=39\Q2W(8^^F1I#3;O[\#459H\_CF[T^]<'!U%/SP1:LGXO59X^Q^.PW$EX M=Q(HK'=VY0/1?^GI2V\.":9/QRZ@3M.7T*R$S0JR<&?+6:YT:0]R5"BT"M5@ MCYRH5O!RD"9$I-._QRUDH&GXU32Y_/PN;#84XN\AT,!=6+@?U'G*$GIC2 B? M5[$4GY%487NP0*%Y$B@T7HX*A5:AZ(S?LBW4>V8"?3!R'CW=S8<>4F.VI),: M9@(&NB;J :Q MK92>4\3E>4_6U-*%2Y?Y@E9[D*-#(79RSYZW["JMSRVFH*3MY#PIANYS'3Z7OO5=2;XJMDW;440'2T]2U9E:LYM'O9% MH9T:0(#RR/>I(!*3XDM]_.G508'T]M 0^F)"I IZ4RDL92=MV7>4SM1:[A^T M$Q:\)D>'0JO.7[Q$%=7G:*=Z'],695++[\/I]4%!]'PO/WJ\TTP.8LQNC_9D MLZ'0*BS. ":.5YWABY*=?HFFUP<'<]"/%6CT;;/?E?C6%B@T3P*%QLO1H= J M+-(N6+.;!L].HJ\P9@\)IJ8]9M&#[=SY>@39.=2V+Z)M(-9Y=6" L(0&C0[ MD4+4?(G+Z-X&#MU?L\ )/@4*+L*N$=$,4!MJ0>YC"4W)HG/K6[:?&\FKE$W*Q M[FW95J 0\YAU-QAM?=&Z7/HA-(VOC&G6UY_[MMGO2GQK"Q2:)X%"XR50:!&. M=2#S*C6[D$)6[>![#-M,BE;@XDL/M'7C_F3VV%1?_.?!$6>1G5�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end XML 9 drna-20200916_htm.xml IDEA: XBRL DOCUMENT 0001399529 2020-09-16 2020-09-16 false 0001399529 8-K 2020-09-16 DICERNA PHARMACEUTICALS, INC. DE 001-36281 20-5993609 33 Hayden Avenue Lexington MA 02421 617 621-8097 false false false false Common Stock, par value $0.0001 per share DRNA NASDAQ false XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover Page
Sep. 16, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Sep. 16, 2020
Entity Registrant Name DICERNA PHARMACEUTICALS, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36281
Entity Tax Identification Number 20-5993609
Entity Address, Address Line One 33 Hayden Avenue
Entity Address, City or Town Lexington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02421
City Area Code 617
Local Phone Number 621-8097
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol DRNA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001399529
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.dicerna.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports drna-20200916.htm drna-20200916.xsd drna-20200916_cal.xml drna-20200916_def.xml drna-20200916_lab.xml drna-20200916_pre.xml drna20200916ex991.htm http://xbrl.sec.gov/dei/2019-01-31 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "drna-20200916.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "drna-20200916_cal.xml" ] }, "definitionLink": { "local": [ "drna-20200916_def.xml" ] }, "inline": { "local": [ "drna-20200916.htm" ] }, "labelLink": { "local": [ "drna-20200916_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "drna-20200916_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "drna-20200916.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "drna", "nsuri": "http://www.dicerna.com/20200916", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "drna-20200916.htm", "contextRef": "i11adc86ba9dd43df822724667cd7cd90_D20200916-20200916", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.dicerna.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "drna-20200916.htm", "contextRef": "i11adc86ba9dd43df822724667cd7cd90_D20200916-20200916", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.dicerna.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0001399529-20-000066-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001399529-20-000066-xbrl.zip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end